phase readout
saveNCT07660666: Feasibility of an Enhanced Symptom Monitoring and Expedited Subspecialty Care Referral Intervention to Improve Side Effect Management for Patients With Melanoma Receiving an Immune Checkpoint Inhibitor
NOT_YET_RECRUITINGupdated 28m ago
community read0 votes
Sponsor: OHSU Knight Cancer Institute. Phase: NA. Conditions: Melanoma
view source ↗
comments(0)
5-min edit window · permanent after that